234 related articles for article (PubMed ID: 26614906)
1. Hairy cell leukemia: Past, present and future.
Getta BM; Park JH; Tallman MS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):269-72. PubMed ID: 26614906
[TBL] [Abstract][Full Text] [Related]
2. Historical overview of hairy cell leukemia.
Andritsos LA; Grever MR
Best Pract Res Clin Haematol; 2015 Dec; 28(4):166-74. PubMed ID: 26614894
[TBL] [Abstract][Full Text] [Related]
3. Hairy cell leukemia.
Dearden C
Best Pract Res Clin Haematol; 2015 Dec; 28(4):163-5. PubMed ID: 26614893
[No Abstract] [Full Text] [Related]
4. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
Else M; Dearden CE; Catovsky D
Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
[TBL] [Abstract][Full Text] [Related]
5. Hairy cell leukemia: update and current therapeutic approach.
Salam L; Abdel-Wahab O
Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
[TBL] [Abstract][Full Text] [Related]
6. Chemoimmunotherapy for hairy cell leukemia.
Ravandi F
Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
[TBL] [Abstract][Full Text] [Related]
7. New insights in the management of patients with hairy cell leukemia.
Cornet E; Damaj G; Troussard X
Curr Opin Oncol; 2015 Sep; 27(5):371-6. PubMed ID: 26154707
[TBL] [Abstract][Full Text] [Related]
8. BRAF inhibitor therapy in HCL.
Dietrich S; Zenz T
Best Pract Res Clin Haematol; 2015 Dec; 28(4):246-52. PubMed ID: 26614903
[TBL] [Abstract][Full Text] [Related]
9. BRAF inhibition in refractory hairy-cell leukemia.
Dietrich S; Glimm H; Andrulis M; von Kalle C; Ho AD; Zenz T
N Engl J Med; 2012 May; 366(21):2038-40. PubMed ID: 22621641
[No Abstract] [Full Text] [Related]
10. Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.
Peyrade F; Re D; Ginet C; Gastaud L; Allegra M; Ballotti R; Thyss A; Zenz T; Auberger P; Robert G
Haematologica; 2013 Feb; 98(2):e20-2. PubMed ID: 23300174
[No Abstract] [Full Text] [Related]
11. Update on the biology and treatment options for hairy cell leukemia.
Jain P; Pemmaraju N; Ravandi F
Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and diagnosis of hairy cell leukemia.
Quest GR; Johnston JB
Best Pract Res Clin Haematol; 2015 Dec; 28(4):180-92. PubMed ID: 26614896
[TBL] [Abstract][Full Text] [Related]
13. BRAF inhibition in hairy cell leukemia with low-dose vemurafenib.
Dietrich S; Pircher A; Endris V; Peyrade F; Wendtner CM; Follows GA; Hüllein J; Jethwa A; Ellert E; Walther T; Liu X; Dyer MJ; Elter T; Brummer T; Zeiser R; Hermann M; Herold M; Weichert W; Dearden C; Haferlach T; Seiffert M; Hallek M; von Kalle C; Ho AD; Gaehler A; Andrulis M; Steurer M; Zenz T
Blood; 2016 Jun; 127(23):2847-55. PubMed ID: 26941398
[TBL] [Abstract][Full Text] [Related]
14. Immunoconjugates in the management of hairy cell leukemia.
Kreitman RJ; Pastan I
Best Pract Res Clin Haematol; 2015 Dec; 28(4):236-45. PubMed ID: 26614902
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic advances in the treatment of hairy cell leukemia.
Andrey J; Saven A
Leuk Res; 2001 May; 25(5):361-8. PubMed ID: 11301103
[No Abstract] [Full Text] [Related]
16. Efficacy of vemurafenib in hairy-cell leukemia.
Samuel J; Macip S; Dyer MJ
N Engl J Med; 2014 Jan; 370(3):286-8. PubMed ID: 24428489
[No Abstract] [Full Text] [Related]
17. Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.
Dietrich S; Hüllein J; Hundemer M; Lehners N; Jethwa A; Capper D; Acker T; Garvalov BK; Andrulis M; Blume C; Schulte C; Mandel T; Meissner J; Fröhling S; von Kalle C; Glimm H; Ho AD; Zenz T
J Clin Oncol; 2013 Jul; 31(19):e300-3. PubMed ID: 23690412
[No Abstract] [Full Text] [Related]
18. Hairy cell leukemia: a 'hair-raising' update.
Topp ZZ; Saven A
Expert Rev Hematol; 2014 Oct; 7(5):659-69. PubMed ID: 25148599
[TBL] [Abstract][Full Text] [Related]
19. Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis.
Maurer H; Haas P; Wengenmayer T; Lübbert M; Duyster J; Zeiser R
Ann Hematol; 2014 Aug; 93(8):1439-40. PubMed ID: 24337488
[No Abstract] [Full Text] [Related]
20. [Successful use of vemurafenib in a patient with resistant hairy cell leukemia].
Urnova ES; Al'-Radi LS; Kuz'mina LA; Kariakina AA; Kovrigina AM; Dvirnyk VN; Iakutik IA; Sudarikov AB; Parovichnikova EN; Savchenko VG
Ter Arkh; 2013; 85(7):76-8. PubMed ID: 24137951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]